Since 1998, we are an independent consultancy focussed on:
ORPHA Strategy's principal, David Schwicker (Biography), has biopharmaceutical expertise spanning more than 25 years, and proposes that strategic “fast to market" thinking can crucially benefit a client’s assets and prospectively accelerate marketing authorisation and market access, pricing and reimbursement.
We were awarded start-up company of the year in Switzerland in the year 2000 for innovation in services.
We provide creative and analytically rigorous advice on strategic problems and devise effective solutions to drive our clients' programmes forward. We do this through collaboration, by channelling and merging our expertise with that of our clients. Our approach has been honed in more than 25 years of consulting experience and will flexibly adapt to specific and unique challenges. Please contact us today to start a strategic discussion about early market access strategy.
ORPHA Strategy Consulting
Phase IV Programs LLC
David Schwicker, Principal
4051 Basle, Switzerland
Tel: +43 676 362 9571